Nils Anders Haegerstrand
Amministratore Delegato presso ANNEXIN PHARMACEUTICALS AB
Profilo
Nils Anders Haegerstrand is currently the Chief Executive Officer at Annexin Pharmaceuticals AB and the Chief Executive Officer at Spatial Transcriptomics AB.
He previously served as the Chief Executive Officer & Head-Research at Newron Sweden AB.
Prior to that, he was the Global Manager at AstraZeneca PLC from 1999 to 2000.
He also held positions as the Manager-Drug Discovery & Development at Karolinska Institutet and Astra Pain Control AB.
Dr. Haegerstrand obtained a doctorate degree from Karolinska Institutet.
Posizioni attive di Nils Anders Haegerstrand
Società | Posizione | Inizio |
---|---|---|
ANNEXIN PHARMACEUTICALS AB | Amministratore Delegato | 01/01/2019 |
Spatial Transcriptomics AB
Spatial Transcriptomics AB Miscellaneous Commercial ServicesCommercial Services Spatial Transcriptomics AB develops technology for RNA sequencing. Its system bridges microscopy and RNA sequencing to generate complete transcriptome data from a single intact tissue sample, and utilizes standard instrumentation for sequencing. The firm's products include ST Tissue Optimization Slide and ST Library Preparation Slide. The company was founded by Jonas Christopher Frisén, Joakim Lundeberg, and Patrik Ståhl and is headquartered in Stockholm, Sweden. | Amministratore Delegato | - |
Precedenti posizioni note di Nils Anders Haegerstrand
Società | Posizione | Fine |
---|---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Amministratore Delegato | 01/06/2017 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2000 |
Astra Pain Control AB | Corporate Officer/Principal | - |
Karolinska Institutet | Corporate Officer/Principal | - |
Formazione di Nils Anders Haegerstrand
Karolinska Institutet | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
ANNEXIN PHARMACEUTICALS AB | Health Technology |
Aziende private | 3 |
---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
Spatial Transcriptomics AB
Spatial Transcriptomics AB Miscellaneous Commercial ServicesCommercial Services Spatial Transcriptomics AB develops technology for RNA sequencing. Its system bridges microscopy and RNA sequencing to generate complete transcriptome data from a single intact tissue sample, and utilizes standard instrumentation for sequencing. The firm's products include ST Tissue Optimization Slide and ST Library Preparation Slide. The company was founded by Jonas Christopher Frisén, Joakim Lundeberg, and Patrik Ståhl and is headquartered in Stockholm, Sweden. | Commercial Services |
Astra Pain Control AB |
- Borsa valori
- Insiders
- Nils Anders Haegerstrand